Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-23-028171
Filing Date
2023-04-07
Accepted
2023-04-07 10:12:55
Documents
79
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2022_nanomixcorp.htm   iXBRL 10-K 1566045
2 DESCRIPTION OF SECURITIES OF NANOMIX CORPORATION f10k2022ex4-27_nanomix.htm EX-4.27 35084
3 LIST OF SUBSIDIARIES f10k2022ex21-1_nanomix.htm EX-21.1 2502
4 CERTIFICATION f10k2022ex31-1_nanomix.htm EX-31.1 18523
5 CERTIFICATION f10k2022ex31-2_nanomix.htm EX-31.2 13655
6 CERTIFICATION f10k2022ex32-1_nanomix.htm EX-32.1 6842
7 CERTIFICATION f10k2022ex32-2_nanomix.htm EX-32.2 6496
8 GRAPHIC fin_001.jpg GRAPHIC 21777
  Complete submission text file 0001213900-23-028171.txt   7566182

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE nnmx-20221231.xsd EX-101.SCH 94833
10 XBRL CALCULATION FILE nnmx-20221231_cal.xml EX-101.CAL 40559
11 XBRL DEFINITION FILE nnmx-20221231_def.xml EX-101.DEF 344773
12 XBRL LABEL FILE nnmx-20221231_lab.xml EX-101.LAB 710861
13 XBRL PRESENTATION FILE nnmx-20221231_pre.xml EX-101.PRE 363369
73 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022_nanomixcorp_htm.xml XML 694820
Mailing Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843
Business Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843 (603) 935-9799
NANOMIX Corp (Filer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54586 | Film No.: 23808043
SIC: 2834 Pharmaceutical Preparations